Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AstraZeneca wins breast cancer approval
1+ hour, 46+ min ago (86+ words) AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan), in combination with pertuzumab, has been approved in the European Union (EU) for first-line treatment of adult patients with unresectable or metastatic HER2-positive breast cancer, the Anglo-Swedish drugmaker said. Published on 09/01/2026 at 08:02 am…...
AstraZeneca, Daiichi Sankyo's Breast Cancer Treatment Combo Wins EU Nod
7+ hour, 4+ min ago (50+ words) Published on 09/01/2026 at 02:44 am EDT AstraZeneca Is Said to Have Explored Bristol Myers Merger August 05, 2026 at 03:00 pm EDT AstraZeneca: BMS acquisition idea holds more red flags than green for AstraZeneca Heading for a major healthcare merger between AstraZeneca and Bristol-Myers…...
Celcuity Submits Supplemental NDA for REVTORPYK in PIK3CA-Mutant Breast Cancer
6+ day, 48+ min ago (34+ words) marketscreener.com Biotechnology & Medical Research Celcuity Submits Supplemental NDA for REVTORPYK in PIK3CA-Mutant Breast Cancer Published on 08/26/2026 at 09:00 am EDT...
AstraZeneca, Daiichi Sankyo's Breast Cancer Drug Combo Gets Approval in China
2+ week, 5+ day ago (50+ words) Published on 08/12/2026 at 09:55 am EDT AstraZeneca Is Said to Have Explored Bristol Myers Merger August 05, 2026 at 03:00 pm EDT AstraZeneca: BMS acquisition idea holds more red flags than green for AstraZeneca Heading for a major healthcare merger between AstraZeneca and Bristol-Myers…...
IceCure Medical Kicks Off Post-Marketing ChoICE Study for ProSense Cryoablation in Low-Risk Breast Cancer Treatment at First U.S. Clinical Site
1+ mon, 4+ day ago (265+ words) marketscreener.com signed agreement with the West Cancer Center & Research Institute, the first clinical site for its post-marketing study for ProSense cryoablation in the treatment of low-risk breast cancer The West Cancer Center & Research Institute in Germantown, Tennessee will serve…...
CSPC Pharma's Application for Breast Cancer Drug Candidate Accepted in China
1+ mon, 2+ week ago (233+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. CSPC Pharmaceutical Group Limited CSPC Pharma's Application for Breast…...
Kazia Therapeutics expands ongoing Phase 1b trial of paxalisib in advanced breast cancer
3+ mon, 6+ day ago (248+ words) marketscreener.com Biotechnology & Medical Research Kazia Therapeutics expands ongoing Phase 1b trial of paxalisib in advanced breast cancer Published on 05/26/2026 at 07:43 am EDT Latest news about Kazia Therapeutics Limited Chart Kazia Therapeutics Limited Income Statement and Estimates This super rating is…...
Personalis secures fourth Medicare coverage decision for Next Personal, expanding breast cancer coverage to pre-surgical treatment monitoring
3+ mon, 1+ week ago (293+ words) marketscreener.com Biotechnology & Medical Research Personalis secures fourth Medicare coverage decision for Next Personal, expanding breast cancer coverage to pre-surgical treatment monitoring Published on 05/20/2026 at 06:54 am EDT Latest news about Personalis, Inc. Income Statement and Estimates This super rating is…...
Provocative Austrian feminist artist Valie Export dies at 85
3+ mon, 2+ week ago (43+ words) Austrian artist Valie Export, whose pioneering work and performance art made her a leading light of the avant-garde feminist scene in postwar Europe, has died in Vienna at the age of 85, her... -May 14, 2026 at 05:52 pm EDT - MarketScreener...
Duality Biotherapeutics' Biologics License Application for Breast Cancer Drug Accepted in China
4+ mon, 3+ week ago (64+ words) marketscreener.com Duality Biotherapeutics' Biologics License Application for Breast Cancer Drug Accepted in China Published on 04/09/2026 at 07:15 am EDT Latest news about Duality Biotherapeutics, Inc. Chart Duality Biotherapeutics, Inc. Income Statement and Estimates Annual profits - Rate of surprise All financial…...